Assessment of apheresis platelets during 5 days of storage: A National Cancer Institute, Cairo University experience. (April 2022)

• Record Type: Journal Article
• Authors: Radwan, Enas M.; Allam, Rasha Mahmoud; Abo El Fetouh, Randa M.; Kamel, Mahmoud M.; Loutfy, Samah A.; Abdel Aziz, Rania S.
• Is Part Of: Transfusion and apheresis science. Volume 61:Number 2(2022)
• Publication Date: 2022-04
• Subjects: Platelet transfusion -- CD63 -- Annexin V; Blood -- Transfusion -- Periodicals; Hemapheresis -- Periodicals; 615.39
• DOI: 10.1016/j.transci.2021.103327
• Languages: English
• ISSNs: 1473-0502

Abstract

Abstract: Background: Platelet transfusion therapy is widely used to prevent hemorrhage in patients with thrombocytopenia and platelet disorders. The platelet concentrate (PC) quality is affected by increased storage time, as reflected in the decreased number of platelets, morphological changes, and impaired functions. This study aimed to analyze the impact of 5 days storage on platelets count and the expression of CD63, and Annexin V as activation markers during PC storage. Methods: Fifty PCs collected from single donors were tested for platelet count on days 0, 3, and 5 using a Sysmex blood counter. CD61, CD63, and Annexin V expression was analyzed by a multicolor Navios flow cytometer. Results: There was a significant decrease in platelet count during 5 days of storage. There was a direct relationship between storage time and degree of platelet activation. CD63 had almost double increased expression on day 5 than day 3. Annexin V showed significantly increased expression on day 3 with minor differences between days 3 and 5. Conclusion: According to standard blood bank conditions, PC stored for 5 days showed a degree of in vitro activation as evidenced by CD63 and Annexin V expression, may lead to reduced therapeutic efficacy. Flow cytometry monitoring platelet activation in PC offers a better understanding of the changes during PC storage and may help improve platelet products.